Quantinno Capital Management’s Definium Therapeutics DFTX Stock Holding History

Quantinno Capital Management’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.32M	Buy	70,682 +30,724	+77%	+$759K	﹤0.01%	1560
2026 Q1	$755K	Buy	39,958 +634	+2%	+$10.8K	﹤0.01%	2400
2025 Q4	$527K	Buy	39,324 +3,582	+10%	+$44.3K	﹤0.01%	2374
2025 Q3	$421K	Buy	35,742 +18,588	+108%	+$173K	﹤0.01%	2172
2025 Q2	$111K	Buy	+17,154	New	+$113K	﹤0.01%	2492

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Quantinno Capital Management's DFTX Position: Q2 2026 in Review

Quantinno Capital Management increased its Definium Therapeutics (DFTX) stake by 77% in Q2 2026, buying an estimated $759K and bringing the position to 70,682 shares worth $3.32M. The position accounts for ﹤0.01% of the portfolio, ranked #1560.

Quantinno Capital Management first reported a position in DFTX in Q2 2025 and has held it in 5 quarters since. 361 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

Quantinno Capital Management held 70,682 shares of Definium Therapeutics worth $3.32M as of Q2 2026.
Quantinno Capital Management bought 30,724 Definium Therapeutics shares in Q2 2026, an estimated $759K.
Definium Therapeutics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #1560 holding.
Quantinno Capital Management first reported a position in Definium Therapeutics in Q2 2025 and has held it in 5 quarters since.
361 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.